Direct comparison of clinical diagnostic sensitivity of saliva from buccal swabs versus combined oro-/nasopharyngeal swabs in the detection of SARS-CoV-2 B.1.1.529 Omicron
•Population: we have studied 107 hospitalized, symptomatic COVID-19 patients.•SARS-CoV-2 B.1.1.529 (Omicron) detection from buccal swab saliva lacks sensitivity.•Reduced sensitivity in buccal swabs observed by RT-PCR and rapid antigen testing.•Differences in sensitivity consistent from day 1–10 afte...
Gespeichert in:
Veröffentlicht in: | Journal of clinical virology 2023-08, Vol.165, p.105496-105496, Article 105496 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Population: we have studied 107 hospitalized, symptomatic COVID-19 patients.•SARS-CoV-2 B.1.1.529 (Omicron) detection from buccal swab saliva lacks sensitivity.•Reduced sensitivity in buccal swabs observed by RT-PCR and rapid antigen testing.•Differences in sensitivity consistent from day 1–10 after symptom onset.
While current guidelines recommend the use of respiratory tract specimens for the direct detection of SARS-CoV-2 infection, saliva has recently been suggested as preferred sample type for the sensitive detection of SARS-CoV-2 B.1.1.529 (Omicron). By comparing saliva collected using buccal swabs and oro-/nasopharyngeal swabs from patients hospitalized due to COVID-19, we aimed at identifying potential differences in virus detection sensitivity between these sample types.
We compare the clinical diagnostic sensitivity of paired buccal swabs and combined oro-/nasopharyngeal swabs from hospitalized, symptomatic COVID-19 patients collected at median six days after symptom onset by real-time polymerase chain reaction (PCR) and antigen test.
Of the tested SARS-CoV-2 positive sample pairs, 55.8% were identified as SARS-CoV-2 Omicron BA.1 and 44.2% as Omicron BA.2. Real-time PCR from buccal swabs generated significantly higher quantification cycle (Cq) values compared to those from matched combined oro-/nasopharyngeal swabs and resulted in an increased number of false-negative PCR results. Reduced diagnostic sensitivity of buccal swabs by real-time PCR was observed already at day one after symptom onset. Similarly, antigen test detection rates were reduced in buccal swabs compared to combined oro-/nasopharyngeal swabs.
Our results suggest reduced clinical diagnostic sensitivity of saliva collected using buccal swabs when compared to combined oro-/nasopharyngeal swabs in the detection of SARS-CoV-2 Omicron in symptomatic individuals.
[Display omitted] |
---|---|
ISSN: | 1386-6532 1873-5967 |
DOI: | 10.1016/j.jcv.2023.105496 |